238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling

• Brandon Higgs,
• Jordan Blum,
• Omar Jabado,
• Suzana Couto,
• Patrick Franken,
• Patricia Coutinho de Souza,
• Nora Pencheva,
• Kate Sasser

Affiliations

Brandon Higgs

Aff2 grid.418152.bMedImmune Gaithersburg MD USA

Jordan Blum

Bristol Myers Squibb Co, Princeton, New Jersey, USA

Omar Jabado

Genmab, Princeton, NJ, USA

Suzana Couto

Genmab, Princeton, NJ, USA

Patrick Franken

Genmab, Princeton, NJ, USA

Patricia Coutinho de Souza

Genmab, Princeton, NJ, USA

Nora Pencheva

Genmab, Princeton, NJ, USA

Kate Sasser

Genmab, Princeton, NJ, USA